3Veyadier A, Obert B, Houllier A, et al. Specific yon Willebrand factor cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood, 2001,98(6) : 1765-1772.
4Nabhan C, Kwaan HC. Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura. Hematol Oncol Clin North Am, 2003,17(1 ) : 177-199.
5Nowacki P, Zdziarska B, Fryze C, et al. Co-existence of thrombocytopenia and hyperleukocytosis (critical period) as a risk factor of haemorrhage into central nervous system in patients with acute leukemias. Haematologia(Budap), 2002, 31 (4) : 347-355.
6Nowacki P, Zdziarska B. "Critical point"as a risk factor of central nervous system hemarrhagic complication in patients with blastic phase of chronic myelogenous leukemia. Acta Haematol Pol, 1993, 24(2) : 147-151.